New look matches focus on transforming GI health ST. LOUIS, MISSOURI (October 3, 2022)  |  Geneoscopy today announced a corporate rebrand and launch. The rebranding

Trial Enrollment Over Indexes in Traditionally Under-Represented Black Community ST. LOUIS, Aug. 23, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests

ST. LOUIS, MISSOURI (JULY 19, 2022) | Earlier this year, President Joe Biden announced plans to reignite the Cancer Moonshot with renewed leadership and new ambitious

ST. LOUIS, June 21, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, today announced the formation of

Data at 2022 Digestive Disease Week Meeting Also Shows RNA-FIT Test to Be Cost-Effective ST. LOUIS, May 23, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on

Trial Enrollment Data Presented at 2022 ASCO Gastrointestinal Cancers Symposium ST. LOUIS, Jan. 20, 2022 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic